This single-center, randomized, double-blind, four-period crossover study will investigate the effect of alcohol on the pharmacodynamics and pharmacokinetics of RO4917838 in healthy volunteers. Healthy volunteers will receive 4 treatments in a randomized order: single dose of RO4917838 and alcohol, RO4917838 and non-alcoholic drink, placebo to RO4917838 and alcohol, and placebo to RO4917838 and non-alcoholic drink.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
25
BIOTRIAL
Rennes, France
Effect of alcohol on pharmacodynamics (Cognitive test battery) of RO4917838
Time frame: Day 1 of each treatment period
Effect of alcohol on pharmacokinetics (Area under the concentration time curve) of RO4917838
Time frame: Days 1, 2, 3, 4, 6, and 8 of each treatment period
Safety: Incidence of adverse events
Time frame: Approximately 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.